ATE284412T1 - Anti-kryptokokkus peptide - Google Patents
Anti-kryptokokkus peptideInfo
- Publication number
- ATE284412T1 ATE284412T1 AT99902120T AT99902120T ATE284412T1 AT E284412 T1 ATE284412 T1 AT E284412T1 AT 99902120 T AT99902120 T AT 99902120T AT 99902120 T AT99902120 T AT 99902120T AT E284412 T1 ATE284412 T1 AT E284412T1
- Authority
- AT
- Austria
- Prior art keywords
- peptides
- fungicidal
- mug
- antifungals
- concentrations
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 230000000855 fungicidal effect Effects 0.000 abstract 3
- 241000221204 Cryptococcus neoformans Species 0.000 abstract 2
- 229940121375 antifungal agent Drugs 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 238000012986 modification Methods 0.000 abstract 2
- 230000004048 modification Effects 0.000 abstract 2
- 201000007336 Cryptococcosis Diseases 0.000 abstract 1
- 241000233866 Fungi Species 0.000 abstract 1
- 238000009792 diffusion process Methods 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 239000007790 solid phase Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7087998P | 1998-01-09 | 1998-01-09 | |
US9170598P | 1998-07-03 | 1998-07-03 | |
PCT/US1999/000418 WO1999035164A1 (en) | 1998-01-09 | 1999-01-08 | Anti-cryptococcal peptides |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE284412T1 true ATE284412T1 (de) | 2004-12-15 |
Family
ID=26751584
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99902120T ATE284412T1 (de) | 1998-01-09 | 1999-01-08 | Anti-kryptokokkus peptide |
Country Status (7)
Country | Link |
---|---|
US (1) | US6620911B1 (de) |
EP (1) | EP1045858B1 (de) |
JP (1) | JP2002500233A (de) |
AT (1) | ATE284412T1 (de) |
CA (1) | CA2315230C (de) |
DE (1) | DE69922484D1 (de) |
WO (1) | WO1999035164A1 (de) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6323315B1 (en) * | 1999-09-10 | 2001-11-27 | Basf Aktiengesellschaft | Dolastatin peptides |
US7256257B2 (en) | 2001-04-30 | 2007-08-14 | Seattle Genetics, Inc. | Pentapeptide compounds and uses related thereto |
PT1545613E (pt) | 2002-07-31 | 2011-09-27 | Seattle Genetics Inc | Conjugados de auristatina e sua utilização para tratamento do cancro, de uma doença autoimune ou de uma doença infecciosa |
KR100459872B1 (ko) * | 2003-05-07 | 2004-12-03 | 삼성전자주식회사 | 트렌치 게이트를 갖는 매몰 채널형 트랜지스터 및 그제조방법 |
SG10201701737XA (en) | 2003-11-06 | 2017-04-27 | Seattle Genetics Inc | Monomethylvaline compounds capable of conjugation to ligands |
JP4931823B2 (ja) * | 2004-10-18 | 2012-05-16 | アムジエン・インコーポレーテツド | チアジアゾール化合物及び使用方法 |
EP1817336B1 (de) | 2004-11-12 | 2019-01-09 | Seattle Genetics, Inc. | Auristatine mit einer aminobenzoesäureeinheit am n-ende |
WO2007008848A2 (en) | 2005-07-07 | 2007-01-18 | Seattle Genetics, Inc. | Monomethylvaline compounds having phenylalanine carboxy modifications at the c-terminus |
JP5171621B2 (ja) | 2005-07-07 | 2013-03-27 | シアトル ジェネティックス, インコーポレイテッド | フェニルアラニン側鎖修飾をc末端に有するモノメチルバリン化合物 |
EP2324838A1 (de) | 2005-09-12 | 2011-05-25 | Abela Pharmaceuticals, Inc. | Zusammensetzungen mit Dimethyl-Sulfoxid |
US7955418B2 (en) | 2005-09-12 | 2011-06-07 | Abela Pharmaceuticals, Inc. | Systems for removing dimethyl sulfoxide (DMSO) or related compounds or odors associated with same |
US8480797B2 (en) | 2005-09-12 | 2013-07-09 | Abela Pharmaceuticals, Inc. | Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors |
WO2007033180A1 (en) | 2005-09-12 | 2007-03-22 | Abela Pharmaceuticals, Inc. | Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds |
US7750116B1 (en) | 2006-02-18 | 2010-07-06 | Seattle Genetics, Inc. | Antibody drug conjugate metabolites |
SG183023A1 (en) | 2007-07-16 | 2012-08-30 | Genentech Inc | Anti-cd79b antibodies and immunoconjugates and methods of use |
RU2557319C2 (ru) | 2007-07-16 | 2015-07-20 | Дженентек, Инк. | ГУМАНИЗИРОВАННЫЕ АНТИТЕЛА ПРОТИВ CD79b И ИММУНОКОНЪЮГАТЫ И СПОСОБЫ ПРИМЕНЕНИЯ |
CA2693473A1 (en) * | 2007-07-17 | 2009-01-22 | Amgen Inc. | Thiadiazole modulators of pkb |
CA2692713A1 (en) | 2007-07-17 | 2009-01-22 | Amgen Inc. | Heterocyclic modulators of pkb |
US20090035848A1 (en) * | 2007-08-03 | 2009-02-05 | Robert Hickey | Moving bed biofilm reactor (mbbr) system for conversion of syngas components to liquid products |
WO2009099728A1 (en) | 2008-01-31 | 2009-08-13 | Genentech, Inc. | Anti-cd79b antibodies and immunoconjugates and methods of use |
US8609105B2 (en) | 2008-03-18 | 2013-12-17 | Seattle Genetics, Inc. | Auristatin drug linker conjugates |
BRPI0921494A2 (pt) | 2008-11-03 | 2018-10-30 | Prad Reasearch And Development Ltd | método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração. |
US9855212B2 (en) | 2009-10-30 | 2018-01-02 | Abela Pharmaceuticals, Inc. | Dimethyl sulfoxide (DMSO) or DMSO and methylsulfonylmethane (MSM) formulations to treat infectious diseases |
EP2579887B1 (de) * | 2010-06-10 | 2014-11-12 | Seattle Genetics, Inc. | Neue auristatin-derivate und ihre verwendung |
US8987209B2 (en) | 2010-09-29 | 2015-03-24 | Seattle Genetics, Inc. | N-carboxyalkyl-auristatin and the use thereof |
US9029406B2 (en) | 2011-03-16 | 2015-05-12 | Seattle Genetics, Inc | N-carboxyalkylauristatins and use thereof |
PT3327027T (pt) | 2011-11-17 | 2021-02-15 | Pfizer | Péptidos citotóxicos e seus conjugados de anticorpos e fármacos |
CA2891280C (en) | 2012-11-24 | 2018-03-20 | Hangzhou Dac Biotech Co., Ltd. | Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules |
WO2014089177A2 (en) | 2012-12-04 | 2014-06-12 | Massachusetts Institute Of Technology | Compounds, conjugates and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines |
EP2972394A4 (de) | 2013-03-15 | 2016-11-02 | Sloan Kettering Inst Cancer | Hsp90-anzielende herzbildgebung und -therapie |
PT3122757T (pt) | 2014-02-28 | 2023-11-03 | Hangzhou Dac Biotech Co Ltd | Ligantes carregados e as suas utilizações em conjugação |
AU2015320678B2 (en) | 2014-09-23 | 2021-07-22 | Genentech, Inc. | Method of using anti-CD79b immunoconjugates |
WO2016130969A1 (en) | 2015-02-13 | 2016-08-18 | George Robert Pettit | Silstatin compounds |
EP3319936A4 (de) | 2015-07-12 | 2019-02-06 | Suzhou M-conj Biotech Co., Ltd. | Brückenlinker zur konjugation von zellbindenden molekülen |
US9839687B2 (en) | 2015-07-15 | 2017-12-12 | Suzhou M-Conj Biotech Co., Ltd. | Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule |
WO2017197045A1 (en) | 2016-05-11 | 2017-11-16 | Movassaghi Mohammad | Convergent and enantioselective total synthesis of communesin analogs |
JP7138350B2 (ja) | 2016-11-14 | 2022-09-16 | ハンジョウ ディーエーシー バイオテック シーオー.,エルティディ. | 共役連結体、該連結体を含有する細胞結合分子-薬物共役体、並びに該共役体及び連結体の使用及び製造方法 |
US11932650B2 (en) | 2017-05-11 | 2024-03-19 | Massachusetts Institute Of Technology | Potent agelastatin derivatives as modulators for cancer invasion and metastasis |
US10640508B2 (en) | 2017-10-13 | 2020-05-05 | Massachusetts Institute Of Technology | Diazene directed modular synthesis of compounds with quaternary carbon centers |
US11629167B2 (en) | 2017-11-09 | 2023-04-18 | Arizona Board Of Regents On Behalf Of Arizona State University | Betulastatin compounds |
US11535634B2 (en) | 2019-06-05 | 2022-12-27 | Massachusetts Institute Of Technology | Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5635483A (en) * | 1992-12-03 | 1997-06-03 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Tumor inhibiting tetrapeptide bearing modified phenethyl amides |
US5504191A (en) * | 1994-08-01 | 1996-04-02 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Human cancer inhibitory pentapeptide methyl esters |
US5599902A (en) * | 1994-11-10 | 1997-02-04 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Cancer inhibitory peptides |
US5663149A (en) * | 1994-12-13 | 1997-09-02 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides |
-
1999
- 1999-01-08 AT AT99902120T patent/ATE284412T1/de not_active IP Right Cessation
- 1999-01-08 EP EP99902120A patent/EP1045858B1/de not_active Expired - Lifetime
- 1999-01-08 US US09/582,951 patent/US6620911B1/en not_active Expired - Fee Related
- 1999-01-08 JP JP2000527559A patent/JP2002500233A/ja active Pending
- 1999-01-08 WO PCT/US1999/000418 patent/WO1999035164A1/en active IP Right Grant
- 1999-01-08 DE DE1999622484 patent/DE69922484D1/de not_active Expired - Fee Related
- 1999-01-08 CA CA002315230A patent/CA2315230C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1045858A4 (de) | 2001-08-29 |
EP1045858A1 (de) | 2000-10-25 |
CA2315230C (en) | 2004-06-29 |
CA2315230A1 (en) | 1999-07-15 |
JP2002500233A (ja) | 2002-01-08 |
WO1999035164A1 (en) | 1999-07-15 |
US6620911B1 (en) | 2003-09-16 |
EP1045858B1 (de) | 2004-12-08 |
DE69922484D1 (de) | 2005-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE284412T1 (de) | Anti-kryptokokkus peptide | |
NO891705D0 (no) | Anti-t-celle reseptordeterminanter som autoimmunsykdomsbehandling. | |
EA200200820A1 (ru) | Пептиды, полученные из казеина, и их применение в терапии | |
BR9609072A (pt) | Fatores de ativação macrófagos derivados de proteìna ligada a vitamina d clonada | |
EP1127170A4 (de) | Menschliche monoklonale antikörper gegen menschlichen pan-hepatitis c virus | |
MXPA01010985A (es) | Metodo y composicion para prevenir o reducir la infeccion por vih por uso de inhibidores para leucina aminopeptidasa. | |
CA2579523A1 (en) | Atad3a-binding molecules for treatment, detection and prevention of cancer | |
BR0009964A (pt) | Peptìdios artificiais com atividade desuperfìcie e sua utilização na preparação de surfactante artificial | |
DE69830492D1 (de) | Antikörper als ARZNEIMITTEL GEGEN LYMPHOCYTISCHE TUMORE (AUSSCHLIESSLICH MYELOME) | |
CY1108330T1 (el) | Ανθρωπινο κυκλοφορητικο ανασταλτικο για ιο πεπτιδιο (virip) και η χρησιμοποιηση του | |
EP0831900A4 (de) | Verfahren zur herstellung von antikörpern gegen e.coli bakterien der familie cs4cfa/1 | |
ATE259654T1 (de) | Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen | |
Despont et al. | Structural studies on a human IgAl myeloma protein with a carboxy-terminal deletion | |
Jerabek et al. | Detection and immunochemical characterization of a primate type C retrovirus-related p30 protein in normal human placentas. | |
WO1996031607A3 (en) | Use of an 'immunodeficiency-virus suppressing lymphokine (isl)' to inhibit the replication of viruses, in particular of retroviruses | |
FR2870126A1 (fr) | Vecteur lentiviral recombinant d'expression d'une proteine de flaviviridae et ses applications comme vaccin | |
HUP0102975A2 (hu) | Kemotaxis-gátló Staphylococcus protein (CHIPS) és annak alkalmazása | |
CA2306441A1 (fr) | Peptides issus de gene env du virus de l'immunodeficience feline et leurs applications | |
Potter et al. | Location of the ATP gamma-phosphate-binding sites on rat liver carbamoyl-phosphate synthetase I. Studies with the ATP analog 5'-p-fluorosulfonylbenzoyladenosine. | |
WO1998023752A3 (de) | Papillomviren, mittel zu deren nachweis sowie zur therapie von durch sie verursachten erkrankungen | |
Broom et al. | Formylmethionyl-leucylphenylalanine and the SOS operon in Escherichia coli: a model of host-bacterial interactions | |
AU1318797A (en) | Peptides and uses thereof for therapy of celiac diseases | |
US6319890B1 (en) | Inhibition of binding of complement Factor H | |
NZ505350A (en) | DNA encoding a tumour antigen peptide (43 kDa) for diagnosis or treatment of tumours | |
WO1999009177A3 (de) | Papillomviren, mittel zu deren nachweis sowie zur therapie von durch sie verursachten erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |